Caffeine improved paroxysmal dyskinesia caused by the PRRT2 mutation

Movement Disorders

Volumn 28, Issue 5, 2013, Pages 683-683

  Lambrecq, Virginie ^a,b   Riant, Florence ^c   Tournier Lasserve, Elisabeth ^c   Michel, Véronique ^a,b   Burbaud, Pierre ^a,b  

^a HÔPITAL PELLEGRIN   (France)

^b INSTITUT DES MALADIES NEURODÉGÉNÉRATIVES   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CAFFEINE CITRATE; CARBAMAZEPINE; LEVODOPA; MEMBRANE PROTEIN; PHENYTOIN; PROLINE RICH TRANSMEMBRANE PROTEIN 2; TOPIRAMATE; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; CHOREA; COFFEE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG TREATMENT FAILURE; DYSKINESIA; FEMALE; GENE MUTATION; HOT FLUSH; HUMAN; INVOLUNTARY MOVEMENT; LETTER; MIGRAINE; NEUROLOGIC EXAMINATION; OROFACIAL DYSKINESIA; PAROXYSMAL DYSKINESIA; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; REST; SLEEP DISORDER; SWEATING; TACHYCARDIA;

CAFFEINE; CHOREA; FEMALE; HUMANS; MEMBRANE PROTEINS; MUTATION; NERVE TISSUE PROTEINS; PHOSPHODIESTERASE INHIBITORS; YOUNG ADULT;

EID: 84877922954     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25450     Document Type: Letter

References (4)

1. Bhatia KP. Paroxysmal dyskinesias. Mov Disord 2011;26:1157-1165.
2. Jarman PR, Bhatia KP, Davie C, et al. Paroxysmal dystonic choreoathetosis: clinical features and investigation of pathophysiology in a large family. Mov Disord 2000;15:648-657.
3. Wang JL, Cao L, Li XH, et al. Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. Brain 2011;134:3493-3501.
4. Prediger RDS. Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms. J Alzheimers Dis 2010;20:S205-S220.